Agilon Health, Inc. (AGL) — Financial statements
Income statement, balance sheet, and cash flow for Agilon Health, Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 5,933↓2.1% | 6,061↑40.4% | 4,316↑80.7% | 2,388↑57.0% | 1,521 | |
| Cost of Revenue | 6,121↑1.1% | 6,056↑42.6% | 4,247↑86.5% | 2,277↑56.4% | 1,456 | |
| Gross Profit | -189↓3996.2% | 5↓93.1% | 70↓37.4% | 111↑69.4% | 66 | |
| Operating Expenses | ||||||
| R&D Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| General & Administrative Expenses | 239↓11.3% | 269↓5.9% | 286↑37.5% | 208↓51.4% | 428 | |
| Selling & Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SG&A Expenses | 239↓11.3% | 269↓5.9% | 286↑37.5% | 208↓51.4% | 428 | |
| Other Expenses | -6↓121.7% | 28↑74.9% | 16↑79.3% | 9↓14.6% | 10 | |
| Operating Expenses | 232↓21.7% | 297↓1.6% | 302↑39.2% | 217↓50.5% | 438 | |
| Total Costs & Expenses | 6,354↑0.0% | 6,353↑39.7% | 4,548↑82.4% | 2,494↑31.7% | 1,894 | |
| Operating Results | ||||||
| Operating Income | -421↓44.1% | -292↓25.8% | -232↓120.3% | -105↑71.7% | -372 | |
| Depreciation & Amortization | 29↑16.9% | 24↑21.3% | 20↑46.4% | 14↓6.1% | 15 | |
| EBITDA | -369↓69.1% | -218↓30.1% | -168↓131.5% | -72↑80.0% | -362 | |
| EBIT | -397↓63.8% | -243↓29.2% | -188↓117.9% | -86↑77.1% | -377 | |
| Interest & Other Income | ||||||
| Net Interest Income | -7↓7.5% | -6↑7.2% | -7↓48.5% | -4↑27.0% | -6 | |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Interest Expense | 7↑7.5% | 6↓7.2% | 7↑48.5% | 4↓27.0% | 6 | |
| Non-Operating Income | -24↑52.3% | -49↓11.6% | -44↓131.0% | -19↓518.3% | 5 | |
| Other Income / Expenses | 17↓60.8% | 43↑15.0% | 38↑156.1% | 15↑237.0% | -11 | |
| Income Before Tax | -404↓62.4% | -249↓28.0% | -194↓114.5% | -91↑76.3% | -383 | |
| Income Tax Expense | 1↓13.8% | 1↑83.4% | 0.79↓51.8% | 2↑85.1% | 0.89 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | -405↓62.0% | -250↓28.2% | -195↓111.5% | -92↑76.0% | -384 | |
| Net Income from Discontinued Operations | 0.00↑100.0% | -10↑85.5% | -68↓364.1% | -15↑36.5% | -23 | |
| Net Income | -405↓55.8% | -260↑0.9% | -263↓146.4% | -107↑73.8% | -406 | |
| Bottom-Line Net Income | -405↓55.8% | -260↑0.9% | -263↓146.4% | -107↑73.8% | -406 | |
| EPS (Basic) | -24.50↓55.6% | -15.75↑1.6% | -16.00↓146.2% | -6.50↑76.1% | -27.25 | |
| EPS (Diluted) | -24.50↓55.6% | -15.75↑1.6% | -16.00↓146.2% | -6.50↑76.1% | -27.25 | |
| Weighted Average Shares | 17↑0.7% | 16↑0.5% | 16↑0.2% | 16↑9.4% | 15 | |
| Weighted Average Diluted Shares | 17↑0.7% | 16↑0.5% | 16↑0.2% | 16↑9.4% | 15 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.